Aktuell 23 mai 2023 Universität Basel und RocketVax stellen neuen COVID-Impfstoff vor Forschende der Universität Basel haben mit dem Biotech-Start-up RocketVax ein neues Konzept für einen Corona-Impfstoff entwickelt. Er beruht auf ...
News 23 mai 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
Success stories 25 mai 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
Aktuell 08 fév 2023 RocketVax erhält frisches Kapital Das Biotech-Start-up RocketVax hat eine weitere Finanzierungsrunde erfolgreich abgeschlossen. Die zusätzlichen Mittel fliessen vor allem in die W...
News 08 fév 2023 RocketVax raises fresh capital The biotech start-up RocketVax has successfully closed another financing round. This additional funding will primarily be used to further develop...
News 01 juin 2021 The Spiez Laboratory at the heart of the WHO’s BioHub system The Spiez Laboratory will be the first facility to be part of the WHO’s BioHub system, an infrastructure that will facilitate the timely sharing ...
Actualités 06 mai 2021 Covid-19 : Berna Biotech Pharma et Swiss Biotech Center développent un vaccin de 2e génération Les entreprises suisses de biotechnologie Berna Biotech Pharma et Swiss Biotech Center s’allient pour développer un vaccin de deuxième génération...
News 06 mai 2021 Berna Biotech Pharma and Swiss Biotech Center to develop second-generation covid-19 vaccine Swiss biotech companies Berna Biotech Pharma and Swiss Biotech Center are joining forces to develop a second-generation vaccine against covid-19....
Third Party Event Webinar COVID-19: Challenges and Opportunities in Brazil and Mexico for Swiss Business